Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals Inc (NAVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,792
  • Shares Outstanding, K 21,645
  • Annual Sales, $ 660 K
  • Annual Income, $ -10,950 K
  • 60-Month Beta 1.83
  • Price/Sales 86.19
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +58.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +235.29%
on 05/06/20
3.50 -18.57%
on 05/22/20
+1.94 (+213.19%)
since 05/04/20
3-Month
0.63 +352.38%
on 04/16/20
3.50 -18.57%
on 05/22/20
+1.76 (+161.47%)
since 03/04/20
52-Week
0.49 +481.63%
on 08/15/19
3.50 -18.57%
on 05/22/20
+1.50 (+111.11%)
since 06/04/19

Most Recent Stories

More News
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress

via NEWMEDIAWIRE -- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics,...

NAVB : 2.85 (+6.74%)
Why Small-Cap ETFs & Stocks Outperformed Last Week

Given the improvements in domestic economy, small-cap stocks led the way higher last week.

CLSN : 2.86 (+5.54%)
RENN : 5.16 (+1.57%)
NAVB : 2.85 (+6.74%)
FYT : 32.81 (+2.38%)
PSCM : 40.88 (+2.08%)
PSCE : 3.87 (+4.53%)
PSCI : 61.52 (+1.51%)
SQLV : 23.08 (+0.48%)
OMP : 8.62 (+2.74%)
CVSI : 0.7799 (+3.99%)
Company News for May 26, 2020

Companies In The News Are: TTWO, XERS, SPLK, NAVB

SPLK : 181.58 (-3.92%)
NAVB : 2.85 (+6.74%)
TTOO : 1.1800 (-9.23%)
XERS : 4.68 (+2.18%)
Thinking about buying stock in Xeris Pharmaceuticals, Aquestive Therapeutics, Navidea Biopharmaceuticals, Sundial Growers, or Hexo Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XERS, AQST, NAVB, SNDL, and HEXO.

HEXO : 0.7300 (+5.71%)
AQST : 5.14 (-3.02%)
NAVB : 2.85 (+6.74%)
SNDL : 0.8100 (-1.23%)
XERS : 4.68 (+2.18%)
Thinking about buying stock in Navidea Biopharmaceuticals, Aurora Cannabis, Under Armour, Onconova Therapeutics, or BJs Wholesale Club?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAVB, ACB, UA, ONTX, and BJ.

ACB : 14.23 (-0.49%)
ACB.TO : 19.01 (-1.25%)
BJ : 34.15 (-5.77%)
NAVB : 2.85 (+6.74%)
ONTX : 0.4515 (-2.61%)
UA : 9.30 (+1.20%)
UAA : 10.41 (+1.07%)
Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis

--Data Support Hypothesis that Tc99m Tilmanocept Imaging Can Provide Early Indicator of Treatment Response

NAVB : 2.85 (+6.74%)
Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its...

NAVB : 2.85 (+6.74%)
Navidea Biopharmaceuticals Regains Commercialization and Distributions Rights in Europe for LYMPHOSEEK(R)

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce...

NAVB : 2.85 (+6.74%)
Navidea Biopharmaceuticals to Host First Quarter 2020 Earnings Conference Call and Corporate Update

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it...

NAVB : 2.85 (+6.74%)
Navidea Biopharmaceuticals Provides Statement Regarding COVID-19 Pandemic

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announces the following...

NAVB : 2.85 (+6.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NAVB with:

Business Summary

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and...

See More

Key Turning Points

2nd Resistance Point 3.03
1st Resistance Point 2.94
Last Price 2.85
1st Support Level 2.68
2nd Support Level 2.51

See More

52-Week High 3.50
Last Price 2.85
Fibonacci 61.8% 2.35
Fibonacci 50% 2.00
Fibonacci 38.2% 1.64
52-Week Low 0.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar